Literature DB >> 12884190

Arterialized partial orthotopic liver transplantation in the mouse: a new model and evaluation of the critical liver mass.

Yinghua Tian1, Rolf Graf, Wolfram Jochum, Pierre-Alain Clavien.   

Abstract

The availability of a model of partial orthotopic liver transplantation (OLT) in the mouse would be an important tool for studying injuries associated with transplantation. The goals of this study were three-fold: (1). to develop a model of partial OLT in the mouse, (2). to determine the minimal graft volume in this model, and (3). to define the injury associated with small volume incompatible with animal survival. Putative grafts of 30% and 50% were prepared. Their weight was 30 +/- 5% and 45 +/- 10%, respectively. Subsequently, 30% and 45% syngeneic partial liver grafts were orthotopically transplanted into C57BL/6 mice. Each recipient receiving a 45% graft survived permanently, whereas those receiving only a 30% graft volume died within 2 to 4 days of surgery. Serum transaminase levels normalized in the 45% graft group within 14 days after surgery. In this group, small foci of necrosis and mild steatosis were noted on histology at postoperative day 2, but no abnormalities were noted after 14 days and 100 days. In contrast, recipients who underwent transplantation with a 30% graft volume showed a comparable amount of necrosis and significant microvesicular steatosis in most hepatocytes 2 days after surgery. Hepatocyte proliferation was reduced in this group when compared with animals who underwent transplantation with a 45% graft volume. In conclusion, partial liver transplantation is feasible in the mouse with a critical graft volume ranging between 30% and 45%. Small liver grafts develop massive microvesicular steatosis and impaired regeneration rapidly leading to animal death.

Entities:  

Mesh:

Year:  2003        PMID: 12884190     DOI: 10.1053/jlts.2003.50170

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

1.  Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration.

Authors:  Jan-Peter Sowa; Jan Best; Tamas Benko; Maximillian Bockhorn; Yanli Gu; Eva-Maria Niehues; Agnieska Bucchi; Eva-Maria Benedetto-Castro; Guido Gerken; Ursula Rauen; Jorg-Friedrich Schlaak
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

2.  Orthotopic mouse liver transplantation to study liver biology and allograft tolerance.

Authors:  Shinichiro Yokota; Shinya Ueki; Yoshihiro Ono; Naoya Kasahara; Angélica Pérez-Gutiérrez; Shoko Kimura; Osamu Yoshida; Noriko Murase; Yoshikazu Yasuda; David A Geller; Angus W Thomson
Journal:  Nat Protoc       Date:  2016-06-02       Impact factor: 13.491

3.  Amphiregulin stimulates liver regeneration after small-for-size mouse liver transplantation.

Authors:  Q Liu; H Rehman; Y Krishnasamy; K Haque; R G Schnellmann; J J Lemasters; Z Zhong
Journal:  Am J Transplant       Date:  2012-06-13       Impact factor: 8.086

4.  Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents.

Authors:  Songqing He; Carl Atkinson; Fei Qiao; Xiaoping Chen; Stephen Tomlinson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-01       Impact factor: 1.232

5.  Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse.

Authors:  Yinghua Tian; Wolfram Jochum; Panco Georgiev; Wolfgang Moritz; Rolf Graf; Pierre-Alain Clavien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 6.  Liver transplantation in the mouse: Insights into liver immunobiology, tissue injury, and allograft tolerance.

Authors:  Shinichiro Yokota; Osamu Yoshida; Yoshihiro Ono; David A Geller; Angus W Thomson
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

7.  Inhibition of transforming growth factor-beta/Smad signaling improves regeneration of small-for-size rat liver grafts.

Authors:  Zhi Zhong; Shigeki Tsukada; Hasibur Rehman; Christopher J Parsons; Tom P Theruvath; Richard A Rippe; David A Brenner; John J Lemasters
Journal:  Liver Transpl       Date:  2010-02       Impact factor: 5.799

8.  Suppression of graft regeneration, not ischemia/reperfusion injury, is the primary cause of small-for-size syndrome after partial liver transplantation in mice.

Authors:  Ning Pan; Xiangwei Lv; Rui Liang; Liming Wang; Qinlong Liu
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

Review 9.  Details determining the success in establishing a mouse orthotopic liver transplantation model.

Authors:  Ting Li; Zheng Hu; Lei Wang; Guo-Yue Lv
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.